| XRTX Shares Outstanding History Table | ||||||||
Below is a table of the XRTX shares outstanding history going back to 9/23/2021:
Also see: XRTX Market Cap History XRTX YTD Return |
XRTX Shares Outstanding History — XORTX Therapeutics Share Count Over Time
As of 11/4/2021 XORTX Therapeutics has 31197 XRTX shares outstanding. Investors often track the XRTX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows XRTX share count trends over time, with 3 historical shares outstanding datapoints presented, dating back to 9/23/2021.
| XRTX Shares Outstanding History Chart | |||||||||
XRTX Historical Shares Outstanding: +293.70% CAGR 
Mouse over chart for data details
| |||||||||
| XRTX Stock Price Chart |
| About XORTX Therapeutics Inc |
| XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. Co. develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. We show 3 historical shares outstanding datapoints in our coverage of XRTX's shares outstanding history. Understanding the changing numbers of XRTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like XRTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching XRTX by allowing them to research XRTX shares outstanding history as well as any other stock in our coverage universe. |
| XRTX Current Stock Quote |
Quotes delayed 20 minutes  Free XRTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| XRTX Share Performance |
| Shares Outstanding Peers |
| XORTX Therapeutics (XRTX) is categorized under the Technology sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
XRX Shares Outstanding History XYZ Shares Outstanding History YAYO Shares Outstanding History YEXT Shares Outstanding History YNDX Shares Outstanding History YOU Shares Outstanding History YY Shares Outstanding History ZAYO Shares Outstanding History ZBRA Shares Outstanding History ZEN Shares Outstanding History More Technology companies » |
XRTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
